Company Filing History:
Years Active: 2014
Title: Keith Jeffrey Lane: Innovator in Ophthalmic Treatments
Introduction
Keith Jeffrey Lane is a notable inventor based in Somerville, MA (US). He has made significant contributions to the field of ophthalmology, particularly in the treatment and prevention of eyelid swelling. His innovative approach combines various active agents to create effective topical formulations.
Latest Patents
Keith Jeffrey Lane holds a patent for a "Method for the treatment and prevention of eyelid swelling." This invention features novel topical ophthalmic formulations that comprise an osmotically active agent and a vasoconstrictor. Suitable osmotically active agents include sodium chloride, dextrose, glycerine, sucrose, mannitol, and sorbitol. The vasoconstrictors used in these formulations include naphazoline and oxymetazoline. The patent outlines methods for using these formulations to treat and prevent eyelid swelling by administering them to the eye surface of a subject in need.
Career Highlights
Keith Jeffrey Lane is associated with Aciex Therapeutics, Inc., where he continues to develop innovative solutions in ophthalmic care. His work has led to advancements that benefit patients suffering from eyelid swelling, showcasing his commitment to improving healthcare outcomes.
Collaborations
Some of his notable coworkers include Matthew Jonathan Chapin and Mark Barry Abelson. Their collaborative efforts contribute to the ongoing research and development in the field of ophthalmology.
Conclusion
Keith Jeffrey Lane's contributions to ophthalmic treatments highlight his innovative spirit and dedication to improving patient care. His patent for the treatment and prevention of eyelid swelling represents a significant advancement in the field.